Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

November 1, 2018

Study Completion Date

November 1, 2018

Conditions
Prostate Cancer Adenocarcinoma
Interventions
RADIATION

Hypo-FLAME study

SBRT technique with 35 Gy in 5 weekly fractions and an additional simultaneously integrated focal boost to the tumor nodule(s) visible on MRI up to 50 Gy. In addition, patients will be asked to undergo 5 additional MRI scans (\~15 min/scan) without contrast enhancement prior to each radiation session as well as blood sampling for translational research (radiogenomics) and Biobank purposes.

Trial Locations (4)

Unknown

UZ Leuven, Leuven

NKI-AvL, Amsterdam

Radboudumc, Nijmegen

UMC Utrecht, Utrecht

All Listed Sponsors
collaborator

The Netherlands Cancer Institute

OTHER

collaborator

Universitaire Ziekenhuizen KU Leuven

OTHER

collaborator

Radboud University Medical Center

OTHER

lead

UMC Utrecht

OTHER

NCT02853110 - Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer | Biotech Hunter | Biotech Hunter